Explore the latest in urology, including recent advances in treatment of UTIs, incontinence, and prostate and bladder cancers.
This Viewpoint examines the use of medical chaperones in the context of sensitive dermatologic examinations and provides recommendations on improving safety and satisfaction for patients and medicolegal protection and cost-saving strategies for clinicians.
A man in his 30s presents with a 14-year history of purulent penile discharge that has not responded to antibiotics or corticosteroids. A pinpoint orifice is found on the glans penis. What is your diagnosis?
This cohort study assesses quality of life and functional outcome of patients with rectal cancer who are followed up via a watch-and-wait approach.
This cohort study of older Swedish adults examines the concordance among 5 common equations for determining estimated glomerular filtration rate for older adults and considers possible sources for discrepancies between measures.
This case report describes a 37-year-old man with a 1-week history of a genital nodule that rapidly ulcerated and with concomitant fever 2 days after anal intercourse.
This retrospective cohort study compares 2 risk calculator systems that compute the probabilities of finding high-grade or any cancer on biopsy results in men undergoing a first prostate biopsy.
This cohort study of men treated at US urology practices uses a national disease registry to analyze trends and variation in the use of active surveillance for the treatment of low-risk prostate cancer.
This systematic review meta-analysis investigates the comparative effectiveness of triplet therapy vs androgen pathway inhibitors doublet therapy for patients with heterogeneous metastatic castration-sensitive prostate cancer.
This cohort study evaluates 2-year outcomes after drug cessation in patients with pentosan polysulfate–associated maculopathy.
This cohort study compares graft survival of kidneys from small and very small pediatric donors in women vs men with end-stage kidney disease.
This randomized clinical trial assesses genitourinary toxic effects after magnetic resonance imaging (MRI)–guided vs computed tomography (CT)–guided stereotactic body radiotherapy for prostate cancer.
This cohort study compares outcomes of treatment with sequential intravesical gemcitabine and docetaxel vs bacillus Calmette-Guérin among patients with high-risk non–muscle-invasive bladder cancer.
This economic evaluation estimates the health care costs associated with using extended-interval fixed dosing instead of standard-interval fixed dosing of immune checkpoint inhibitors in a simulated cohort of patients with urothelial cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.